Trial ID or NCT#



not recruiting iconNOT RECRUITING


This trial is designed to assess the safety and efficacy of flibanserin in the treatment of premenopausal women with Hypoactive Sexual Desire Disorder (HSDD) that meets standard diagnostic criteria. Efficacy for flibanserin will be assessed vs. a parallel placebo group.

Official Title

A Twenty Four Week, Randomized, Double-Blind, Placebo-Controlled, Safety and Efficacy Trial of Flibanserin 50mg Every Evening and Flibanserin 100mg Every Evening in Women With Hypoactive Sexual Desire Disorder in North America

Eligibility Criteria

Ages Eligible for Study: Older than 18 Years
Sexes Eligible for Study: Female
Accepts Healthy Volunteers: No


Hugh Brent Solvason PhD MD
Hugh Brent Solvason PhD MD
Clinical Professor, Psychiatry and Behavioral Sciences
Leah S. Millheiser, MD,FACOG,IF
Leah S. Millheiser, MD,FACOG,IF
Obstetrician and Gynecologist (OB-GYN), Sexual health specialist
Clinical Assistant Professor, Obstetrics & Gynecology - General

Contact us to find out if this trial is right for you.


Jennifer Howden
(650) 498-6128